ROS1 Gene Mutation clinical trials at UC Irvine

1 research study open to eligible people

Genetic Testing in Guiding Treatment for Patients With Brain Metastases
open to eligible people ages 18 years and up
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K,…
Orange, California and other locations

Last updated: March 28, 2025